High-Fat Diet Not Associated With Increased Estrogen in Postmenopausal Women

Publication
Article
OncologyONCOLOGY Vol 15 No 1
Volume 15
Issue 1

There is no evidence that a high-fat diet predisposes older women to breast cancer, report researchers from Harvard Medical School. It has long been thought that dietary fat can increase production of sex hormones, including estrogen, and

There is no evidence that a high-fat diet predisposesolder women to breast cancer, report researchersfrom Harvard Medical School. It has long been thought that dietary fat canincrease production of sex hormones, including estrogen, and thus put women(especially older women) at risk for breast cancer. This study in 381postmenopausal women, however, revealed just the opposite. The researchers foundthat women in the study who ate less fat than is typical among US women actuallyhad higher levels of estrogen in their blood, making it unlikely that eating alow-fat diet will lead to lower levels of estrogen.

"This is good news for women," said the study’s leadauthor, Michelle Holmes, MD, DrPH, assistant professor of medicine at HarvardMedical School. "It’s one less thing they need to worry about if they areconcerned about breast cancer. We found no evidence that higher fat intake isassociated with higher levels of any reproductive hormones in this group ofpostmenopausal women."

Lower Fat Intake Leads to Higher Hormone Levels

Dr. Holmes added that lowering fat intake to reduce hormonelevels, and thus the risk of breast cancer, probably is not a useful strategy."It does not seem likely that eating a low-fat diet in midlife can lowerhormone production," said Dr. Holmes.

The research team took blood samples from study participants tomeasure the amount of hormones present in their blood. Those hormones includedestradiol as well as "male" hormones such as testosterone. Researchersalso estimated the different kinds of fat the women ate, based on a food surveyconducted twice during the 4-year study. None of the women were using hormonereplacement therapy.

The researchers found that as women increased the amount of fatin their diets, the levels of six hormones declined. The study results werepublished in a recent issue of the Journal of Clinical Oncology (18:3668-3676,2000).

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content